{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:40:10Z","timestamp":1793137210640,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vaccine.2023.10.057","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T19:14:19Z","timestamp":1698520459000},"page":"7076-7083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials\u2019 records between 2018 and 2023"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-4822","authenticated-orcid":false,"given":"Maha","family":"Salloum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antea","family":"Paviotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Bastiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Van Geertruyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.10.057_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10928-020-09687-z","article-title":"Challenges in conducting clinical research studies in pregnant women","volume":"47","author":"McKiever","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.vaccine.2023.10.057_b0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3138\/ijfab.5.2.82","article-title":"How are pregnant women vulnerable research participants?","volume":"5","author":"Wild","year":"2012","journal-title":"Int J Feminist Approaches Bioethics"},{"key":"10.1016\/j.vaccine.2023.10.057_b0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/medethics-2016-103955","article-title":"Vulnerability of pregnant women in clinical research","volume":"43","author":"van der Zande","year":"2017","journal-title":"J Med Ethics"},{"key":"10.1016\/j.vaccine.2023.10.057_b0025","unstructured":"Thalidomide. Science Museum n.d. https:\/\/www.sciencemuseum.org.uk\/objects-and-stories\/medicine\/thalidomide (accessed November 4, 2022)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/bdrc.21035","article-title":"Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects","volume":"99","author":"Reed","year":"2013","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.vaccine.2023.10.057_b0035","unstructured":"Commissioner O of the. Gender Studies in product development: historical overview. FDA; 2020."},{"key":"10.1016\/j.vaccine.2023.10.057_b0040","first-page":"45","article-title":"Encouraging maternal sacrifice: how regulations governing the consumption of pharmaceuticals during pregnancy prioritize fetal safety over maternal health and autonomy","volume":"39","author":"Donley","year":"2014","journal-title":"Rev Law Soc Change"},{"key":"10.1016\/j.vaccine.2023.10.057_b0045","unstructured":"Commissioner O of the. Regulations, guidance, and reports related to women\u2019s health. FDA; 2020."},{"key":"10.1016\/j.vaccine.2023.10.057_b0050","unstructured":"Research C for DE and. Division of pediatric and maternal health - clinical trials in pregnant women. FDA; 2019."},{"key":"10.1016\/j.vaccine.2023.10.057_b0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157","author":"Adam","year":"2011","journal-title":"Am J Med Genet Part C: Semin Med Genet"},{"key":"10.1016\/j.vaccine.2023.10.057_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2023.10.057_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jppr.1605","article-title":"Navigating off-label and unlicensed medicines use in obstetric and paediatric clinical practice","volume":"49","author":"Gray","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.vaccine.2023.10.057_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2014.00009","article-title":"Obstetric pharmacokinetic dosing studies are urgently needed","volume":"2","author":"McCormack","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2023.10.057_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.vaccine.2023.10.057_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575197","article-title":"Maternal immunological adaptation during normal pregnancy","volume":"11","author":"Abu-Raya","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2021.02.002","article-title":"Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored","volume":"225","author":"Caritis","year":"2021","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.940644","article-title":"Pharmacokinetic data in pregnancy: a review of available literature data and important considerations in collecting clinical data","volume":"9","author":"Coppola","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.vaccine.2023.10.057_b0095","unstructured":"Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development; 2022. https:\/\/www.nichd.nih.gov\/about\/advisory\/PRGLAC (accessed October 3, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0100","unstructured":"Research C for DE and. Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials. US Food and Drug Administration; 2020. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pregnant-women-scientific-and-ethical-considerations-inclusion-clinical-trials (accessed January 20, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0105","series-title":"Clinical research involving pregnant women","first-page":"227","article-title":"Ethics and research with pregnant women: lessons from HIV\/AIDS","author":"Little","year":"2016"},{"key":"10.1016\/j.vaccine.2023.10.057_b0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jwh.2017.6857","article-title":"Beyond \u201cVessels and Vectors\u201d: a global review of registered HIV-related clinical trials with pregnant women","volume":"28","author":"Wickremsinhe","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.vaccine.2023.10.057_b0115","doi-asserted-by":"crossref","unstructured":"Faden R, Kass N, McGraw D. Women as vessels and vectors: Lessons from the HIV epidemic. In: Feminism and bioethics: beyond reproduction; 1996. p. 252\u201381.","DOI":"10.1093\/oso\/9780195085686.003.0010"},{"key":"10.1016\/j.vaccine.2023.10.057_b0120","unstructured":"Call to accelerate the study of new drugs for HIV in pregnant and breastfeeding women n.d. https:\/\/www.who.int\/news\/item\/01-12-2021-call-to-accelerate-the-study-of-new-drugs-for-hiv-in-pregnant-and-breastfeeding-women (accessed October 3, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0125","unstructured":"Ending the evidence gap for pregnancy, HIV and co\u2010infections: ethics guidance from the PHASES project - PMC n.d. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8673925\/ (accessed January 24, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2020.09.005","article-title":"The historical aspects of vaccination in pregnancy","volume":"76","author":"Mackin","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0135","unstructured":"History of influenza vaccination n.d. https:\/\/www.who.int\/news-room\/spotlight\/history-of-vaccination\/history-of-influenza-vaccination (accessed April 7, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0140","unstructured":"Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1995;44:1\u201322."},{"key":"10.1016\/j.vaccine.2023.10.057_b0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12978-017-0430-2","article-title":"Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials","volume":"14","author":"Gomes","year":"2017","journal-title":"Reprod Health"},{"key":"10.1016\/j.vaccine.2023.10.057_b0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/trstmh\/traa011","article-title":"Lassa fever in pregnancy: a systematic review and meta-analysis","volume":"114","author":"Kayem","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2023.10.057_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2019.01.011","article-title":"Pregnant women & vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response","volume":"39","author":"Krubiner","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.057_b0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0b013e3182a9ca67","article-title":"Exclusion of pregnant women from industry-sponsored clinical trials","volume":"122","author":"Shields","year":"2013","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2023.06.073","article-title":"Exclusion of pregnant people from emergency vaccine clinical trials: a systematic review of clinical trial protocols and reporting from 2009 to 2019","author":"Minchin","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.057_b0170","article-title":"Searching clinical trials registers: guide for systematic reviewers","volume":"377","author":"Hunter","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.10.057_b0175","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2021.10.048","article-title":"Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12\u201313 February 2020","volume":"39","author":"Voss","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.057_b0180","article-title":"Safety of administering live vaccines during pregnancy: a systematic review and meta-analysis of pregnancy outcomes","volume":"8","author":"Laris-Gonz\u00e1lez","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.10.057_b0185","unstructured":"Yellow Fever Vaccine n.d. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5907a1.htm (accessed October 4, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/vaccines8010038","article-title":"Being pregnant during the Kivu Ebola Virus outbreak in DR Congo: the rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas","volume":"8","author":"Schwartz","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2023.10.057_b0195","unstructured":"HPV Vaccination Recommendations | CDC; 2022. https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/recommendations.html (accessed March 28, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13063-017-2402-9","article-title":"Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach","volume":"19","author":"van der Graaf","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2023.10.057_b0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3201\/eid2603.191018","article-title":"Pregnancy outcomes among women receiving rVSV\u0394-ZEBOV-GP Ebola vaccine during the sierra leone trial to introduce a vaccine against Ebola","volume":"26","author":"Legardy-Williams","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.10.057_b0210","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/AOG.0b013e3181c2ca21","article-title":"Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6\/11\/16\/18 vaccine: a combined analysis of five randomized controlled trials","volume":"114","author":"Garland","year":"2009","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145122","article-title":"Differential globalization of industry- and non-industry\u2013sponsored clinical trials","volume":"10","author":"Atal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.10.057_b0220","unstructured":"EMA. Paediatric investigation plans. European Medicines Agency; 2018. https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/paediatric-medicines\/paediatric-investigation-plans (accessed March 24, 2023)."},{"key":"10.1016\/j.vaccine.2023.10.057_b0225","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.vaccine.2020.08.059","article-title":"Pregnant women\u2019s perceptions of risks and benefits when considering participation in vaccine trials","volume":"38","author":"Jaffe","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.10.057_b0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.wombi.2017.12.009","article-title":"Facilitators and barriers to pregnant women\u2019s participation in research: a systematic review","volume":"31","author":"van der Zande","year":"2018","journal-title":"Women Birth"},{"key":"10.1016\/j.vaccine.2023.10.057_b0235","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","article-title":"Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action","volume":"9","author":"Taylor","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2023.10.057_b0240","article-title":"Registered clinical trials comprising pregnant women in China: a cross-sectional study","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2023.10.057_b0245","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.whi.2022.06.004","article-title":"Exclusion of reproductive-aged women in COVID-19 vaccination and clinical trials","volume":"32","author":"Kons","year":"2022","journal-title":"Women\u2019s Health Issues"},{"key":"10.1016\/j.vaccine.2023.10.057_b0250","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/eurheartj\/ehab103","article-title":"Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity","volume":"42","author":"Van Spall","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23012598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T20:10:34Z","timestamp":1720037434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23012598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0264410X23012598"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials\u2019 records between 2018 and 2023","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}